awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33414349-F8945C61-E8ED-409B-A891-88F802D6E302
Q33414349-F8945C61-E8ED-409B-A891-88F802D6E302
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414349-F8945C61-E8ED-409B-A891-88F802D6E302
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
P2860
Q33414349-F8945C61-E8ED-409B-A891-88F802D6E302
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414349-F8945C61-E8ED-409B-A891-88F802D6E302
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d405f751b9b253b66afc43913b470e498945d73f
P2860
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials